Cargando…
Pretargeted immunoscintigraphy in patients with medullary thyroid carcinoma.
To evaluate the use of pretargeted immunoscintigraphy (ISG) in the diagnosis and follow-up of patients with medullary thyroid carcinoma (MTC), we studied 25 patients with histologically proven disease; ISG was repeated after surgery in two patients. The antibody, either an anticarcinoembryonic antig...
Autores principales: | Magnani, P., Paganelli, G., Songini, C., Samuel, A., Sudati, F., Siccardi, A. G., Fazio, F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074693/ https://www.ncbi.nlm.nih.gov/pubmed/8795589 |
Ejemplares similares
-
Diagnosis of persistent ovarian carcinoma with three-step immunoscintigraphy
por: Magnani, P, et al.
Publicado: (2000) -
Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer
por: Kraeber–Bodéré, F., et al.
Publicado: (2009) -
Immunoscintigraphy, Practical Aspects and Clinical Applications
por: Maraveyas, A., et al.
Publicado: (1992) -
Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches
por: Bodet-Milin, Caroline, et al.
Publicado: (2019) -
Pretargeted adjuvant radioimmunotherapy with Yttrium-90-biotin in malignant glioma patients: A pilot study
por: Grana, C, et al.
Publicado: (2002)